Viruses: A frameshift in time
When an RNA virus infects a cell, ribosomes inside the cell decode the genetic information in the virus’s RNA to produce proteins, which are then used to make more viral particles. A single-stranded RNA molecule consists of a sequence of nucleotides that the ribosome reads three at a time. Each triplet, or codon, codes for either an amino acid (the building blocks that form proteins), or signals for the ribosome to start or stop reading the RNA sequence. Therefore, each nucleotide sequence can therefore be ‘read’ by ribosomes in three different ways, or ‘reading frames’, depending on which nucleotide the ribosome starts reading from. Additionally, an ‘open reading frame’ or ORF is a sequence of nucleotide triplets that code for amino acids located between two stop codons in the same reading frame.
Almost all cellular proteins are encoded in a single reading frame, with only rare exceptions (Baranov et al., 2015). Viruses, however, often break this rule in a process termed ‘programmed ribosomal frameshifting’ (Firth and Brierley, 2012; Atkins et al., 2016). This mechanism occurs at specific locations in the nucleotide sequence called frameshift sites, where a proportion of the ribosomes translating the RNA will shift back or forward one nucleotide and start decoding a different reading frame. Meanwhile, the rest of the ribosomes continue reading the original frame. Thus, the same segment of an RNA molecule can be read to produce two protein molecules with distinct amino acid sequences simultaneously.
It is unclear exactly why viruses employ programmed ribosomal frameshifting. One suggestion is that this mechanism allows for a more compact organization of genetic material. Another is that frameshifting could be used for setting a specific ratio between different viral proteins. Most commonly, ribosomal frameshifting occurs during the synthesis of viral polyproteins, long amino acid chains that are processed into smaller proteins with distinct functions. The advantage of organizing protein synthesis in this way is that only one RNA molecule is needed to encode multiple proteins. However, if all these proteins were synthesized as a part of a single polyprotein, they would occur strictly in a one-to-one ratio after being processed. This would be wasteful, since these proteins are needed in different quantities.
So how could the optimal proportions of these proteins be achieved? The low efficiency frameshifting mechanism solves the problem. Proteins that the virus needs in large quantities are encoded early in the sequence in an open reading frame herein referred to as ORF1A, while proteins that the virus requires in lower quantities are encoded in a different but overlapping downstream reading frame, herein referred to as ORF1B (Figure 1). ORF1A is decoded according to standard rules, producing a shorter version of the viral polyprotein. ORF1B, on the other hand, is only read by the ribosomes that change reading frame at the frameshift site between ORF1A and ORF1B, resulting in a longer polyprotein.

Schematic representation showing how RNA is decoded in the vicinity of the frameshift site between two open reading frames, ORF1A and ORF1B.
Top: most ribosomes (yellow) decoding ORF1A terminate at the stop codon (red arrow), release the protein (not shown) and dissociate from the RNA (gray curve). A small proportion of ribosomes, however, shift frames to decode ORF1B. The ribosome at the frameshift site is outlined with a fuzzy cloud. Center: the density of ribosome footprints (the lines under each of the ribosomes) revealed by ribosome profiling maps to the positions occupied by ribosomes on the RNA molecule. The ratio between the ribosome footprint density at ORF1A and at ORF1B can be used as a measure of frameshifting efficiency. Bottom: schematic of the three possible reading frames in a molecule of RNA, each represented by a bar and denoted by –1, 0, and +1. The clock-like nature of the frameshift site drawing alludes to the temporal regulation of frameshifting as revealed by Cook et al.
This type of frameshifting is sometimes referred to as canonical due to its common occurrence in RNA viruses. It was originally assumed that the ratio of products generated from ORF1A and ORF1B was fixed throughout the virus’s time in the cell (Jacks and Varmus, 1985). Now, in eLife, Ian Brierley, Andrew Firth, Ying Fang and colleagues – including Georgia Cook (University of Cambridge) as first author – report evidence suggesting that this ratio changes over the course of infection (Cook et al., 2022).
The team (who are based at various institutes in the United Kingdom, the United States and China) studied how viral gene expression changes during porcine reproductive and respiratory syndrome virus (PRRSV) infection. To do this, Cook et al. used a technique called ribosome profiling to map which parts of the virus’s RNA sequence were being translated by ribosomes at any given time (Ingolia et al., 2009). These mappings, called ribosome footprints, revealed several new ORFs that encoded previously uncharacterized viral protein products.
Ribosome profiling can also be used to compare how efficiently different proteins are synthesized. For example, in the PRRSV genome the density of footprints mapped to ORF1A is higher than the footprint density at ORF1B. This happens because only a small proportion of the ribosomes reading ORF1A shift reading frame and proceed to ORF1B (Figure 1). By calculating the ratio of footprint densities between the two open reading frames it is possible to estimate frameshifting efficiency.
The PRRSV genome is known to contain two frameshift sites: the canonical site between ORF1A and ORF1B, which is used by many viruses, and a second, rarer frameshift site in ORF1A that results in the production of a shorter polyprotein. The genome of a related virus, called the encephalomyocarditis virus, has been shown to have a similar secondary frameshift site that is stimulated by a viral protein (Napthine et al., 2017). The concentration of this viral protein was found to increase over the course of an infection and cause more ribosomes to shift to the other reading frame. However, by measuring the efficiency of both frameshifting sites in PRRSV, Cook et al. showed that this temporal change is not limited to the protein-stimulated frameshifting, but also occurs in the canonical site between ORF1A and ORF1B.
This finding challenges the current paradigm that regards the canonical frameshifting between ORF1A and ORF1B as a mechanism that enables a fixed ratio between polyprotein products. The temporal change detected in PRRSV suggests that the efficiency of frameshifting may also be altered in other viruses over time. If so, it would be interesting to determine what factors mediate the regulation of the frameshifting event between ORF1A and ORF1B.
An open question that remains is how changes in frameshifting efficiency along the course of an infection relate to the virus’s virulence and transmissibility. It is possible that changes in efficiency are simply due to alterations in the infected cell that make ribosomes more prone to shifting to another reading frame. However, it may be that regulating the efficiency of frameshifting is beneficial for the virus. Alternatively, the antiviral response of the host may induce frameshifting to alter the ratio of viral proteins and negatively impact the virus. Indeed, it has been previously reported that the formation of viral particles can be disrupted by altering frameshifting efficiency (Dulude et al., 2006).
Whatever the case, the search for cellular factors responsible for changes in frameshifting has already begun (Riegger and Caliskan, 2022). The identification of these factors will provide researchers with new targets for modulating frameshifting efficiency in viruses, potentially revealing new ways to fight off viral infections.
References
-
Non-canonical translation in RNA virusesThe Journal of General Virology 93:1385–1409.https://doi.org/10.1099/vir.0.042499-0
-
Protein-directed ribosomal frameshifting temporally regulates gene expressionNature Communications 8:15582.https://doi.org/10.1038/ncomms15582
-
Thinking outside the frame: impacting genomes capacity by programmed ribosomal frameshiftingFrontiers in Molecular Biosciences 9:842261.https://doi.org/10.3389/fmolb.2022.842261
Article and author information
Author details
Publication history
Copyright
© 2022, Yordanova and Baranov
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 1,502
- views
-
- 128
- downloads
-
- 4
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Cell Biology
- Chromosomes and Gene Expression
Meiotic crossover recombination is essential for both accurate chromosome segregation and the generation of new haplotypes for natural selection to act upon. This requirement is known as crossover assurance and is one example of crossover control. While the conserved role of the ATPase, PCH-2, during meiotic prophase has been enigmatic, a universal phenotype when pch-2 or its orthologs are mutated is a change in the number and distribution of meiotic crossovers. Here, we show that PCH-2 controls the number and distribution of crossovers by antagonizing their formation. This antagonism produces different effects at different stages of meiotic prophase: early in meiotic prophase, PCH-2 prevents double-strand breaks from becoming crossover-eligible intermediates, limiting crossover formation at sites of initial double-strand break formation and homolog interactions. Later in meiotic prophase, PCH-2 winnows the number of crossover-eligible intermediates, contributing to the designation of crossovers and ultimately, crossover assurance. We also demonstrate that PCH-2 accomplishes this regulation through the meiotic HORMAD, HIM-3. Our data strongly support a model in which PCH-2’s conserved role is to remodel meiotic HORMADs throughout meiotic prophase to destabilize crossover-eligible precursors and coordinate meiotic recombination with synapsis, ensuring the progressive implementation of meiotic recombination and explaining its function in the pachytene checkpoint and crossover control.
-
- Cancer Biology
- Chromosomes and Gene Expression
Despite exciting developments in cancer immunotherapy, its broad application is limited by the paucity of targetable antigens on the tumor cell surface. As an intrinsic cellular pathway, nonsense-mediated decay (NMD) conceals neoantigens through the destruction of the RNA products from genes harboring truncating mutations. We developed and conducted a high-throughput screen, based on the ratiometric analysis of transcripts, to identify critical mediators of NMD in human cells. This screen implicated disruption of kinase SMG1’s phosphorylation of UPF1 as a potential disruptor of NMD. This led us to design a novel SMG1 inhibitor, KVS0001, that elevates the expression of transcripts and proteins resulting from human and murine truncating mutations in vitro and murine cells in vivo. Most importantly, KVS0001 concomitantly increased the presentation of immune-targetable human leukocyte antigens (HLA) class I-associated peptides from NMD-downregulated proteins on the surface of human cancer cells. KVS0001 provides new opportunities for studying NMD and the diseases in which NMD plays a role, including cancer and inherited diseases.